BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doustimotlagh AH, Eftekhari M. Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin. Clin Nutr ESPEN 2021;43:197-9. [PMID: 34024514 DOI: 10.1016/j.clnesp.2021.02.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 He M, Feng L, Chen Y, Gao B, Du Y, Zhou L, Li F, Liu H. Polydatin attenuates tubulointerstitial fibrosis in diabetic kidney disease by inhibiting YAP expression and nuclear translocation. Front Physiol 2022;13:927794. [DOI: 10.3389/fphys.2022.927794] [Reference Citation Analysis]
2 Li Z, Zhou L, Du Y, Li H, Feng L, Li X, Han X, Liu H, Badr DA. Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury via SIRT6-Mediated Autophagy Activation. Oxidative Medicine and Cellular Longevity 2022;2022:1-19. [DOI: 10.1155/2022/9035547] [Reference Citation Analysis]
3 Amin MN, Bahoosh SR, Eftekhari M, Hosseinzadeh L. Herbal Sources of Magnesium as a Promising Multifaceted Intervention for the Management of COVID-19. Natural Product Communications 2022;17:1934578X2211162. [DOI: 10.1177/1934578x221116235] [Reference Citation Analysis]
4 Pérez-torres I, Soto ME, Guarner-lans V, Manzano-pech L, Soria-castro E. The Possible Role of Glucose-6-Phosphate Dehydrogenase in the SARS-CoV-2 Infection. Cells 2022;11:1982. [DOI: 10.3390/cells11131982] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Bahoosh SR, Shokoohinia Y, Eftekhari M. Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-COV-2. Daru 2022;30:245-52. [PMID: 35112323 DOI: 10.1007/s40199-022-00435-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Vejarano R, Luján-corro M. Red Wine and Health: Approaches to Improve the Phenolic Content During Winemaking. Front Nutr 2022;9:890066. [DOI: 10.3389/fnut.2022.890066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang M, Qin K, Zhai X. Combined Network Pharmacology, Molecular Docking, and Experimental Verification Approach to Investigate the Potential Mechanisms of Polydatin Against COVID-19. Natural Product Communications 2022;17:1934578X2210953. [DOI: 10.1177/1934578x221095352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Huang L, Chen J, Li X, Huang M, Liu J, Qin N, Zeng Z, Wang X, Li F, Yang H. Polydatin Improves Sepsis-Associated Encephalopathy by Activating Sirt1 and Reducing p38 Phosphorylation. J Surg Res 2022;276:379-93. [PMID: 35447391 DOI: 10.1016/j.jss.2022.03.008] [Reference Citation Analysis]
9 De Angelis M, Della-Morte D, Buttinelli G, Di Martino A, Pacifici F, Checconi P, Ambrosio L, Stefanelli P, Palamara AT, Garaci E, Ricordi C, Nencioni L. Protective Role of Combined Polyphenols and Micronutrients against Influenza A Virus and SARS-CoV-2 Infection In Vitro. Biomedicines 2021;9:1721. [PMID: 34829949 DOI: 10.3390/biomedicines9111721] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
10 Eftekhari M, Enayati A, Doustimotlagh AH, Farzaei MH, Yosifova Aneva I. Natural Products in Combination Therapy for COVID-19: QT Prolongation and Urgent Guidance. Natural Product Communications 2021;16:1934578X2110324. [DOI: 10.1177/1934578x211032471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]